advertisement
Li M 31
Showing records 1 to 25 | Display all abstracts from Li M117498 The anterior scleral thickness in primary open-angle glaucoma with high myopia
Li M
Frontiers in medicine 2024; 11: 1356839
117013 Epidemiological variations and trends in glaucoma burden in the Belt and Road countries
Chen X
BMC Ophthalmology 2024; 24: 195
118853 Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Zhou H
Journal of immunology research 2024; 2024: 5009637
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
118490 The application of functional imaging in visual field defects: a brief review
Cheng W
Frontiers in neurology 2024; 15: 1333021
117013 Epidemiological variations and trends in glaucoma burden in the Belt and Road countries
Zhao Y
BMC Ophthalmology 2024; 24: 195
117498 The anterior scleral thickness in primary open-angle glaucoma with high myopia
Chen L
Frontiers in medicine 2024; 11: 1356839
118490 The application of functional imaging in visual field defects: a brief review
Liu J
Frontiers in neurology 2024; 15: 1333021
118853 Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Zhang R
Journal of immunology research 2024; 2024: 5009637
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
118490 The application of functional imaging in visual field defects: a brief review
Jiang T
Frontiers in neurology 2024; 15: 1333021
118853 Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Li M
Journal of immunology research 2024; 2024: 5009637
117013 Epidemiological variations and trends in glaucoma burden in the Belt and Road countries
Zhang A
BMC Ophthalmology 2024; 24: 195
117498 The anterior scleral thickness in primary open-angle glaucoma with high myopia
Luo Z
Frontiers in medicine 2024; 11: 1356839
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G; Lin J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117498 The anterior scleral thickness in primary open-angle glaucoma with high myopia
Yan X
Frontiers in medicine 2024; 11: 1356839
117013 Epidemiological variations and trends in glaucoma burden in the Belt and Road countries
Zhou Y
BMC Ophthalmology 2024; 24: 195
118490 The application of functional imaging in visual field defects: a brief review
Li M
Frontiers in neurology 2024; 15: 1333021
118853 Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Wang F
Journal of immunology research 2024; 2024: 5009637
117013 Epidemiological variations and trends in glaucoma burden in the Belt and Road countries
Li M
BMC Ophthalmology 2024; 24: 195
118853 Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Gao Y
Journal of immunology research 2024; 2024: 5009637
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang W; Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
117013 Epidemiological variations and trends in glaucoma burden in the Belt and Road countries
Cheng X
BMC Ophthalmology 2024; 24: 195
118853 Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling
Fang K; Zong J
Journal of immunology research 2024; 2024: 5009637
118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042
